• LAST PRICE
    80.5800
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 80.5800
  • Day Range
    ---
  • 52 Week Range
    Low 47.6700
    High 85.6500
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 81.71
TimeVolumeKRYS
09:32 ET72082.06
09:35 ET10082.99
09:42 ET39883
09:44 ET30082.7
09:46 ET20081.9
09:48 ET259682.31
09:50 ET343982.175
09:51 ET50081.81
09:53 ET150082.32
09:55 ET40082.85
09:57 ET314682.73
10:02 ET250581.87
10:04 ET756482.145
10:06 ET397781.88
10:08 ET80081.73
10:11 ET30081.39
10:13 ET30081.36
10:15 ET30081.36
10:18 ET10081.22
10:20 ET30081.19
10:22 ET33780.38
10:24 ET10080.17
10:26 ET10080.53
10:27 ET10080.6
10:31 ET10080.83
10:33 ET10081.11
10:44 ET20081.21
10:51 ET170081.4
10:54 ET40081.53
10:56 ET10081.32
10:58 ET20080.89
11:00 ET40080.7
11:02 ET10080.71
11:03 ET342180.72
11:05 ET48180.725
11:07 ET150080.88
11:09 ET302580.885
11:12 ET90080.91
11:14 ET180081.28
11:16 ET190981.2
11:18 ET20081
11:20 ET10080.945
11:21 ET10080.78
11:25 ET40080.79
11:30 ET10080.85
11:32 ET89080.85
11:34 ET40081.01
11:36 ET70081.06
11:38 ET30081.05
11:43 ET50081.3
11:52 ET10081.735
11:54 ET10081.575
11:56 ET10081.66
11:57 ET100081.42
12:06 ET30081.24
12:08 ET100080.85
12:12 ET40080.75
12:14 ET10080.64
12:15 ET40080.77
12:17 ET40080.875
12:19 ET202281.15
12:21 ET50081.25
12:24 ET188081.3
12:26 ET216581.15
12:28 ET120081.11
12:30 ET41181
12:32 ET20081.1
12:35 ET30081.01
12:37 ET80081.25
12:39 ET60081.25
12:42 ET20081.025
12:44 ET40081
12:48 ET70081.06
12:50 ET10081.05
12:51 ET20080.98
12:53 ET50080.94
12:57 ET130081.075
01:00 ET30081.05
01:04 ET180881.09
01:06 ET140081.04
01:08 ET30080.95
01:09 ET250081.115
01:11 ET333681.5
01:13 ET20081.46
01:20 ET12081.5172
01:22 ET10081.465
01:24 ET70081.22
01:26 ET10081.19
01:27 ET40081.195
01:29 ET87981.08
01:31 ET40081.185
01:33 ET40081.11
01:38 ET100081.16
01:40 ET40081.08
01:42 ET130081.15
01:45 ET50081
01:49 ET10081.025
01:51 ET20080.735
01:58 ET10080.99
02:00 ET10080.99
02:02 ET30081
02:07 ET10080.87
02:09 ET20080.82
02:12 ET10080.46
02:14 ET10080.43
02:18 ET10080.21
02:21 ET10080.17
02:23 ET20080.01
02:25 ET20080.14
02:27 ET10079.93
02:30 ET30080.08
02:32 ET40079.89
02:34 ET10079.78
02:36 ET10079.63
02:38 ET50079.82
02:39 ET10079.83
02:43 ET60079.685
02:45 ET80079.72
02:48 ET20079.64
02:50 ET40079.67
02:52 ET20079.79
02:56 ET20079.555
02:57 ET20079.39
02:59 ET30079.17
03:03 ET40079.45
03:06 ET40079.66
03:08 ET30079.8
03:10 ET10079.76
03:15 ET30079.86
03:17 ET20079.76
03:19 ET20079.7
03:21 ET45880.06
03:26 ET10080.215
03:28 ET10080.21
03:30 ET30080.155
03:32 ET50080.2
03:33 ET10080.23
03:35 ET40080.31
03:37 ET10080.39
03:39 ET391580.59
03:42 ET458380.675
03:44 ET130080.415
03:46 ET115280.31
03:48 ET210080.32
03:50 ET180080.305
03:51 ET465080.665
03:53 ET205480.1
03:55 ET586680.045
03:57 ET901180.19
04:00 ET5155580.58
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKRYS
Krystal Biotech Inc
2.1B
-15.5x
---
United StatesSWTX
SpringWorks Therapeutics Inc
2.1B
-6.6x
---
United StatesCLDX
Celldex Therapeutics Inc
2.1B
-19.9x
---
United StatesPRME
Prime Medicine Inc
1.9B
-11.1x
---
United StatesAKRO
Akero Therapeutics Inc
2.2B
-14.2x
---
United StatesIMVT
Immunovant Inc
2.4B
-12.0x
---
As of 2023-02-03

Company Information

Krystal Biotech, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of redosable gene therapies for patients living with debilitating diseases. It has developed a gene delivery platform that enables off-the-shelf treatments for serious dermatology and respiratory diseases. Its platform consists of an engineered viral vector derived from the herpes simplex virus type 1 (HSV-1) that it has optimized for local and repeat gene transfer to epithelial cells. Its product candidates in various stages of clinical and preclinical development include Vyjuvek for dystrophic epidermolysis bullosa (Dystrophic EB), KB105 for TGM1-deficient autosomal recessive congenital ichthyosis (ARCI), KB104 for Netherton Syndrome, KB407 for Cystic Fibrosis (CF), and KB408 for Alpha-1 antitrypsin deficiency (AATD). Its KB301 is for aesthetic skin conditions. Its subsidiary, Jeune Aesthetics, Inc, focuses on preclinical and clinical studies for aesthetic skin conditions.

Contact Information

Headquarters
2100 Wharton St Ste 701PITTSBURGH, PA, United States 15203-1973
Phone
412-586-5830
Fax
302-655-5049

Executives

Chairman of the Board, President, Chief Executive Officer
Krish Krishnan
Founder, Chief Operating Officer, Director, President - Research and Development
Suma Krishnan
President - Jeune, Inc
Bhushan Hardas
Chief Accounting Officer
Kathryn Romano
Chief Business Officer
Jing Marantz

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.1B
Revenue (TTM)
$0.00
Shares Outstanding
25.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.87
EPS
$-5.20
Book Value
$23.55
P/E Ratio
-15.5x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.